Sardari Nia P, Colpaert C, Blyweert B, Kui B, Vermeulen P, Ferguson M, Hendriks J, Weyler J, Pezzella F, Van Marck E, Van Schil P
Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Belgium.
Br J Cancer. 2004 Oct 4;91(7):1293-300. doi: 10.1038/sj.bjc.6602134.
An essential prerequisite of nonangiogenic growth appears to be the ability of the tumour to preserve the parenchymal structures of the host tissue. This morphological feature is visible on a routine tissue section. Based on this feature, we classified haematoxylin and eosin-stained tissue sections from 279 patients with non-small-cell lung cancer into three growth patterns: destructive (angiogenic; n=196), papillary (intermediate; n=38) and alveolar (nonangiogenic; n=45). A Cox multiple regression model was used to test the prognostic value of growth patterns together with other relevant clinicopathological factors. For overall survival, growth pattern (P=0.007), N-status (P=0.001), age (P=0.020) and type of operation (P=0.056) were independent prognostic factors. For disease-free survival, only growth pattern (P=0.007) and N-status (P<0.001) had an independent prognostic value. Alveolar (hazard ratio=1.825, 95% confidence interval=1.117-2.980, P=0.016) and papillary (hazard ratio=1.977, 95% confidence interval=1.169-3.345, P=0.011) growth patterns were independent predictors of poor prognosis. The proposed classification has an independent prognostic value for overall survival as well as for disease-free survival, providing a possible explanation for survival differences of patients in the same disease stage.
非血管生成性生长的一个基本前提似乎是肿瘤保留宿主组织实质结构的能力。这种形态学特征在常规组织切片上可见。基于这一特征,我们将279例非小细胞肺癌患者苏木精和伊红染色的组织切片分为三种生长模式:浸润性(血管生成性;n = 196)、乳头状(中间型;n = 38)和肺泡型(非血管生成性;n = 45)。采用Cox多元回归模型来检验生长模式与其他相关临床病理因素的预后价值。对于总生存期,生长模式(P = 0.007)、N分期(P = 0.001)、年龄(P = 0.020)和手术类型(P = 0.056)是独立的预后因素。对于无病生存期,只有生长模式(P = 0.007)和N分期(P < 0.001)具有独立的预后价值。肺泡型(风险比=1.825,95%置信区间=1.117 - 2.980,P = 0.016)和乳头状(风险比=1.977,95%置信区间=1.169 - 3.345,P = 0.011)生长模式是预后不良的独立预测因素。所提出的分类对于总生存期和无病生存期均具有独立的预后价值,为同一疾病阶段患者的生存差异提供了一种可能的解释。